Aspira Women's Health Inc. AWH
0.08 USD 0.00 (+0.00%)
At closeFeb 10, 2026, 4:00 PM EST
0.082 Day range 0.082
52-week range unavailable
- YTD
- 0.00%
- 1 year
- 0.00%
News
prnewswire.com AWH to Hold Third Quarter 2026 Earnings Conference Call on Thursday, November 12, 2026 NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis…
prnewswire.com AWH Stockholders Approve Reverse Stock Split, a Prerequisite to a U.S. Exchange Listing Board authorized to determine ratio and timing; no action needed from stockholders at this time NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the…
prnewswire.com AWH Reports Second Quarter 2026 Financial Results Generated Q2 2026 net revenue of $126.1 million and Adjusted EBITDA¹ of $29.1 million Scaled retail footprint to 55 locations, up from 48 at the end of Q1 2026² Grew market share by ~5% across our…
prnewswire.com AWH Reminds Stockholders to Vote on Reverse Stock Split for August 28 Special Meeting Board unanimously recommends voting "FOR" - approval requires a majority of all outstanding shares, so every vote counts Proxies must be received by 11:00 a.m. Eastern Time on August 26, 2026, or…
prnewswire.com AWH to Hold Second Quarter 2026 Earnings Conference Call on Wednesday, August 12, 2026 NEW YORK, July 28, 2026 /PRNewswire/ -- Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis…
prnewswire.com AWH Announces Reverse Stock Split Vote in Support of Planned U.S. Exchange Uplisting Virtual Special Meeting of Stockholders to be held August 28, 2026 NEW YORK, July 13, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH-U.CN) (OTCQX:…
prnewswire.com AWH Files DEA Registration Applications for State-Licensed Medical Cannabis Operations NEW YORK, June 30, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator and…
accessnewswire.com Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation AUSTIN, TX AND CLEVELAND, OH / ACCESS Newswire / May 26,…
prnewswire.com AWH Reports First Quarter 2026 Financial Results Generated Q1 2026 net revenue of $116.9 million and Adjusted EBITDA1 of $26.3 million 51-location footprint to date, with five dispensaries added in 20262 Ranked No. 2 brand house in Illinois,…
prnewswire.com AWH to Hold First Quarter 2026 Earnings Conference Call on Wednesday, May 13, 2026 NEW YORK, April 29, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator…
accessnewswire.com Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease…
prnewswire.com AWH Announces Fourth Quarter and Full Year 2025 Results Delivered Q4 2025 and FY 2025 revenue of $120.5 million and $500.6 million Expanded Adjusted EBITDA Margin 1 to 25.1% in Q4 2025 and 23.4% for FY 2025 Maintained strong liquidity with $ 85.7 million…
prnewswire.com AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million Balance sheet strength with…
accessnewswire.com Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update AUSTIN, TX / ACCESS Newswire / November 14, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQX:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading…
prnewswire.com AWH Announces Third Quarter 2025 Financial Results Delivered Q3 2025 Net Revenue of $124.7 million Achieved Q3 2025 Adjusted EBITDA1 of $31.1 million, representing a 24.9% margin Focused margin optimization fueled sequential Adjusted Gross Margin 1…
accessnewswire.com Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc.,…
prnewswire.com AWH to Hold Third Quarter 2025 Earnings Conference Call on Monday, November 10, 2025 NEW YORK , Oct. 20, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today…
prnewswire.com AWH Closes $9.3 Million Mortgage Financing on Three Ohio Properties NEW YORK , Sept. 30, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, entered…
accessnewswire.com Aspira Women's Health Announces Equity Capital Infusion of $3.06 Million in Private Placement and Warrant Exercise $2.95 Million PIPE $112 thousand warrant exercise AUSTIN, TX / ACCESS Newswire / September 18, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's…
accessnewswire.com Aspira Women's Health Appoints New Chief Financial Officer New Executive Brings 20+ Years of Accounting, Capital Markets & Biotechnology Experience AUSTIN, TX / ACCESS Newswire / September 4, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company")…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Earnings Scheduled For November 14, 2024
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Earnings Scheduled For March 28, 2024 Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
benzinga.com Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
benzinga.com Earnings Scheduled For August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 54 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's session, 40 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 29 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 69 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 148 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 199 companies reached new 52-week lows.- benzinga.com Earnings Scheduled For May 11, 2023 Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its…
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 164 companies hit new 52-week lows.
- benzinga.com Earnings Scheduled For March 22, 2023 Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million.
- benzinga.com Earnings Scheduled For November 10, 2022 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
- benzinga.com Nasdaq Turns Lower; Crude Oil Rises Sharply U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday.
- benzinga.com Earnings Scheduled For August 10, 2022 Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
- benzinga.com This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
- benzinga.com Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.
- benzinga.com Alibaba, Zoom Video And 76 Biggest Movers From Yesterday Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
- benzinga.com Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.